Tag: Respiratory syncytial virus

Health

FDA approves GSK’s RSV vaccine for high-risk adults ages 50 to 59, expanding shot’s reach

June 8, 2024
Newseum Global

[ad_1] A view shows GlaxoSmithKline headquarters in London, Britain, January 17, 2022. Hannah Mckay | Reuters…

Health

CDC recommends Pfizer maternal RSV vaccine to protect infants, paving way for fall availability

September 23, 2023
Newseum Global

[ad_1] A doctor vaccinates an infant against respiratory syncytial virus (RSV) in a treatment room of…

Newseum Global